Skip to search formSkip to main contentSkip to account menu

Nystatin:Susc:Pt:Isolate:Qn:MLC

Known as: Nystatin:Susceptibility:Point in time:Isolate:Quantitative:Minimum Lethal Concentration, Nistatin Islt MLC, Nistatina:Susc:Pt:Isolado:Qn:Concentração letal mínima 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
A highly reliable 26nm 64GB MLC E2NAND (E2: Embedded-ECC & Enhanced-efficiency) flash memory has been successfully developed. To… 
2011
2011
A monolithic 64Gb MLC NAND flash based on 21nm process technology has been developed for the first time. The device consists of 4… 
2011
2011
This paper presents the power losses evaluation and comparison of three different Mega Watt MW scale multilevel converter… 
2009
2009
The aim of this study was to investigate a novel method for verification of the dose distribution for intensity modulated… 
2009
2009
Purpose Volumetric modulated arc therapy (VMAT) is a rotational IMRT modality that combines dose rate modulation with gantry and… 
2008
2008
Purpose:To quantify the relative peripheral doses (PD) to healthy tissues outside the treated region for different intensity… 
2007
2007
Quality assurance (QA) of the multileaf collimator (MLC) is a critical step for the delivery of intensity modulated radiation… 
2005
2005
Purpose: To compare different MLC systems for intensity modulated stereotactic radiotherapy (IMSRT) of intracranial tumours with… 
1987
1987
A substrate-specific calmodulin-dependent myosin light-chain kinase (MLCK) was purified 45,000-fold to near homogeneity from…